Annual Net Income
$137.54 M
+$46.16 M+50.51%
31 December 2023
Summary:
Amphastar Pharmaceuticals annual net profit is currently $137.54 million, with the most recent change of +$46.16 million (+50.51%) on 31 December 2023. During the last 3 years, it has risen by +$136.14 million (+9703.64%). AMPH annual net income is now at all-time high.AMPH Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
$40.43 M
+$2.48 M+6.54%
30 September 2024
Summary:
Amphastar Pharmaceuticals quarterly net profit is currently $40.43 million, with the most recent change of +$2.48 million (+6.54%) on 30 September 2024. Over the past year, it has dropped by -$8.79 million (-17.86%). AMPH quarterly net income is now -17.86% below its all-time high of $49.22 million, reached on 30 September 2023.AMPH Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
$157.72 M
-$8.79 M-5.28%
30 September 2024
Summary:
Amphastar Pharmaceuticals TTM net profit is currently $157.72 million, with the most recent change of -$8.79 million (-5.28%) on 30 September 2024. Over the past year, it has increased by +$22.43 million (+16.58%). AMPH TTM net income is now -5.28% below its all-time high of $166.51 million, reached on 30 June 2024.AMPH TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMPH Net Income Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +50.5% | -17.9% | +16.6% |
3 y3 years | +9703.6% | +36.8% | +337.1% |
5 y5 years | +2497.1% | +2986.2% | +204.3% |
AMPH Net Income High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +9703.6% | -17.9% | +154.7% | -5.3% | +337.1% |
5 y | 5 years | at high | +2497.1% | -17.9% | +744.5% | -5.3% | >+9999.0% |
alltime | all time | at high | +1385.6% | -17.9% | +666.1% | -5.3% | +1136.8% |
Amphastar Pharmaceuticals Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $40.43 M(+6.5%) | $157.72 M(-5.3%) |
June 2024 | - | $37.95 M(-12.1%) | $166.51 M(+7.6%) |
Mar 2024 | - | $43.18 M(+19.4%) | $154.69 M(+12.5%) |
Dec 2023 | $137.54 M(+50.5%) | $36.17 M(-26.5%) | $137.54 M(+1.7%) |
Sept 2023 | - | $49.22 M(+88.4%) | $135.29 M(+32.7%) |
June 2023 | - | $26.12 M(+0.4%) | $101.94 M(+9.4%) |
Mar 2023 | - | $26.03 M(-23.2%) | $93.17 M(+1.9%) |
Dec 2022 | $91.39 M(+47.1%) | $33.91 M(+113.6%) | $91.39 M(+18.3%) |
Sept 2022 | - | $15.87 M(-8.5%) | $77.23 M(-15.0%) |
June 2022 | - | $17.35 M(-28.5%) | $90.91 M(+11.8%) |
Mar 2022 | - | $24.25 M(+22.7%) | $81.33 M(+30.9%) |
Dec 2021 | $62.12 M(+4327.4%) | $19.76 M(-33.1%) | $62.12 M(+72.1%) |
Sept 2021 | - | $29.55 M(+280.4%) | $36.08 M(+245.2%) |
June 2021 | - | $7.77 M(+54.1%) | $10.45 M(+319.0%) |
Mar 2021 | - | $5.04 M(-180.4%) | $2.50 M(+77.8%) |
Dec 2020 | $1.40 M(-97.1%) | -$6.27 M(-260.1%) | $1.40 M(-78.9%) |
Sept 2020 | - | $3.92 M(-2141.1%) | $6.65 M(+64.6%) |
June 2020 | - | -$192.00 K(-104.9%) | $4.04 M(-92.2%) |
Mar 2020 | - | $3.95 M(-484.9%) | $52.02 M(+6.3%) |
Dec 2019 | $48.94 M(-952.9%) | -$1.03 M(-178.3%) | $48.94 M(-5.6%) |
Sept 2019 | - | $1.31 M(-97.3%) | $51.83 M(-2.0%) |
June 2019 | - | $47.79 M(+5405.4%) | $52.91 M(+2229.9%) |
Mar 2019 | - | $868.00 K(-53.5%) | $2.27 M(-139.6%) |
Dec 2018 | -$5.74 M | $1.87 M(-21.9%) | -$5.74 M(-15.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2018 | - | $2.39 M(-183.7%) | -$6.82 M(-25.1%) |
June 2018 | - | -$2.85 M(-60.0%) | -$9.11 M(+112.7%) |
Mar 2018 | - | -$7.14 M(-1007.4%) | -$4.28 M(-214.2%) |
Dec 2017 | $3.65 M(-62.9%) | $787.00 K(+694.9%) | $3.75 M(-865.5%) |
Sept 2017 | - | $99.00 K(-95.0%) | -$490.00 K(-114.8%) |
June 2017 | - | $1.97 M(+120.8%) | $3.30 M(-59.9%) |
Mar 2017 | - | $893.00 K(-125.9%) | $8.22 M(-16.3%) |
Dec 2016 | $9.82 M(-452.4%) | -$3.45 M(-188.8%) | $9.82 M(-52.8%) |
Sept 2016 | - | $3.89 M(-43.6%) | $20.81 M(+49.6%) |
June 2016 | - | $6.89 M(+177.0%) | $13.91 M(+3689.9%) |
Mar 2016 | - | $2.49 M(-67.0%) | $367.00 K(-113.2%) |
Dec 2015 | -$2.79 M(-74.0%) | $7.53 M(-350.4%) | -$2.79 M(-78.3%) |
Sept 2015 | - | -$3.01 M(-54.7%) | -$12.84 M(-15.6%) |
June 2015 | - | -$6.65 M(+899.5%) | -$15.21 M(+56.1%) |
Mar 2015 | - | -$665.00 K(-73.6%) | -$9.74 M(-8.9%) |
Dec 2014 | -$10.70 M(-190.2%) | -$2.52 M(-53.1%) | -$10.70 M(+68.5%) |
Sept 2014 | - | -$5.38 M(+355.8%) | -$6.35 M(+462.4%) |
June 2014 | - | -$1.18 M(-27.1%) | -$1.13 M(-114.4%) |
Mar 2014 | - | -$1.62 M(-188.5%) | $7.86 M(-33.7%) |
Dec 2013 | $11.86 M(-34.4%) | $1.83 M(-1250.3%) | $11.86 M(+18.2%) |
Sept 2013 | - | -$159.00 K(-102.0%) | $10.03 M(-1.6%) |
June 2013 | - | $7.81 M(+227.9%) | $10.19 M(+327.9%) |
Mar 2013 | - | $2.38 M | $2.38 M |
Dec 2012 | $18.09 M(+133.4%) | - | - |
Dec 2011 | $7.75 M | - | - |
FAQ
- What is Amphastar Pharmaceuticals annual net profit?
- What is the all time high annual net income for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals annual net income year-on-year change?
- What is Amphastar Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals quarterly net income year-on-year change?
- What is Amphastar Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals TTM net income year-on-year change?
What is Amphastar Pharmaceuticals annual net profit?
The current annual net income of AMPH is $137.54 M
What is the all time high annual net income for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual net profit is $137.54 M
What is Amphastar Pharmaceuticals annual net income year-on-year change?
Over the past year, AMPH annual net profit has changed by +$46.16 M (+50.51%)
What is Amphastar Pharmaceuticals quarterly net profit?
The current quarterly net income of AMPH is $40.43 M
What is the all time high quarterly net income for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly net profit is $49.22 M
What is Amphastar Pharmaceuticals quarterly net income year-on-year change?
Over the past year, AMPH quarterly net profit has changed by -$8.79 M (-17.86%)
What is Amphastar Pharmaceuticals TTM net profit?
The current TTM net income of AMPH is $157.72 M
What is the all time high TTM net income for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high TTM net profit is $166.51 M
What is Amphastar Pharmaceuticals TTM net income year-on-year change?
Over the past year, AMPH TTM net profit has changed by +$22.43 M (+16.58%)